Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
14.55%
↑ 243% above average
Average (16q)
-10.20%
Historical baseline
Range
High:28.77%
Low:-100.00%
Volatility
-1263.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 14.55% |
| Q2 2025 | -7.84% |
| Q1 2025 | 15.00% |
| Q4 2024 | -1.69% |
| Q3 2024 | -13.46% |
| Q2 2024 | 28.77% |
| Q1 2024 | 15.12% |
| Q4 2023 | -30.30% |
| Q3 2023 | -4.76% |
| Q2 2023 | -23.53% |
| Q1 2023 | -34.21% |
| Q4 2022 | 19.15% |
| Q3 2022 | -6.82% |
| Q2 2022 | 21.43% |
| Q1 2022 | -64.71% |
| Q4 2021 | -100.00% |
| Q3 2021 | 0.00% |